The Combination of Prednisone and Recombinant Human Thrombopoietin for Treatment of Immune Thrombocytopenia in Pregnancy
Status:
Recruiting
Trial end date:
2022-09-01
Target enrollment:
Participant gender:
Summary
Randomized, open-label study to compare the efficacy and safety of prednisone plus
recombinant human thrombopoietin (rhTPO) compared to prednisone monotherapy for the treatment
of immune thrombocytopenia in pregnancy